regadenoson has been researched along with n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine in 2 studies
| Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) |
|---|---|---|---|---|---|
| 321 | 53 | 264 | 214 | 5 | 58 |
| Protein | Taxonomy | regadenoson (IC50) | n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 2.1002 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.0017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elzein, E; Maa, T; Palle, V; Wu, Y; Zablocki, J; Zeng, D | 1 |
| Gao, ZG; Jacobson, KA | 1 |
1 review(s) available for regadenoson and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
| Article | Year |
|---|---|
Adenosine receptors as therapeutic targets.
Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship | 2006 |
1 other study(ies) available for regadenoson and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
| Article | Year |
|---|---|
2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Cricetinae; Humans; Molecular Structure; Receptor, Adenosine A3; Structure-Activity Relationship | 2004 |